SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001999371-24-004297
Filing Date
2024-04-01
Accepted
2024-04-01 16:34:34
Documents
113
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT tnxp-10k_123123.htm   iXBRL 10-K 3033989
2 DESCRIPTION OF REGISTRANT'S SECURITIES ex4-06.htm EX-4.06 18660
3 TONIX PHARMACEUTICALS HOLDING CORP. INSIDER TRADING POLICY ex19-01.htm EX-19.01 112936
4 LIST OF SUBSIDIARIES ex21-01.htm EX-21.01 4164
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-01.htm EX-23.01 3093
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 10107
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 9610
8 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER ex32-01.htm EX-32.01 5431
9 TONIX PHARMACEUTICALS HOLDING CORP. COMPENSATION RECOVERY POLICY ex97-01.htm EX-97.01 32501
  Complete submission text file 0001999371-24-004297.txt   10812656

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE tnxp-20231231.xsd EX-101.SCH 85280
11 XBRL CALCULATION FILE tnxp-20231231_cal.xml EX-101.CAL 102148
12 XBRL DEFINITION FILE tnxp-20231231_def.xml EX-101.DEF 361181
13 XBRL LABEL FILE tnxp-20231231_lab.xml EX-101.LAB 590585
14 XBRL PRESENTATION FILE tnxp-20231231_pre.xml EX-101.PRE 489907
117 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-10k_123123_htm.xml XML 1193150
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36019 | Film No.: 24809998
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)